Local angel fund has made new investments in three early-stage companies
The Winston-Salem Partners Roundtable (WSPR) Fund is proud to support the growth of three local startups with new rounds of funding for the following companies:
KeraVet Bio is the maker of KeraVet® Gel, a revolutionary new prescription hydrogel developed with the human-animal bond in mind. It can reduce the time spent in E-collars, simplifies wound and incision care, and improves client compliance all while supporting better, faster healing.
on Holiday produces craft wine spritzes combining high quality sauvignon blanc with whole natural ingredients like fresh fruit juice and botanicals, creating a flavorful escape from the ordinary.
Patient Ready is a leader in AI-powered clinical education, creating capable, confident and compassionate clinicians.
“We are thrilled to be able to continue to support these companies,” said Stan Parker, General Partner of the WSPR Fund. “Each investment is a follow on from earlier WSPR Fund investments and represents the growing confidence we have in the founders and their ability to successfully scale their companies.”
Launched in 2021, the WSPR Fund is a Winston-Salem–based angel investment group with more than 80 members. Since inception, the fund has invested $4.3 million across 23 investments in 13 early-stage companies, fueling innovation and growth in the region. The fund is administered by Greater Winston-Salem Inc.
“Winston-Salem is an ideal market for early-stage growth with robust support for startups, including the WSPR Fund,” says Mark Owens, President and CEO of Greater Winston-Salem Inc. “By fueling these companies early on, we are embracing their potential to generate local jobs and investment far into the future.”
The WSPR Fund accepts applications from early-stage companies seeking funding on an ongoing basis.